<table class="naaccr-summary-table naaccr-borders">
    <tr>
        <th class="naaccr-summary-header naaccr-borders">Item #</th>
        <th class="naaccr-summary-header naaccr-borders">Length</th>
        <th class="naaccr-summary-header naaccr-borders">Source of Standard</th>
        <th class="naaccr-summary-header naaccr-borders">Year Implemented</th>
        <th class="naaccr-summary-header naaccr-borders">Version Implemented</th>
        <th class="naaccr-summary-header naaccr-borders">Year Retired</th>
        <th class="naaccr-summary-header naaccr-borders">Version Retired</th>
        <th class="naaccr-summary-header naaccr-borders">Column #</th>
    </tr>
    <tr>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">3816</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">2</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">NAACCR</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">2018</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">18</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1994 - 1995</td>
    </tr>
</table>

<br/><strong>NAACCR XML</strong>: Tumor.brainMolecularMarkers<br/><br/>


<div class='content chap10-para-head'><strong><strong>Description</strong></strong></div>
<div class='content chap10-para'>Multiple brain molecular markers have become standard pathology components necessary for diagnosis. This data item captures clinically important brain cancer subtypes identified by molecular markers that are not distinguishable by ICD-O-3 codes.</div>
<div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div>
<div class='content chap10-para'>Collection of these clinically important brain cancer subtypes has been recommended by CBTRUS.</div>
<div class='content chap10-para'><strong>Codes</strong></div>
<div class='content chap10-para'>
    <table>
        <tr class='code-row'>
            <td class='code-nbr'>01</td>
            <td class='code-desc'>Diffuse astrocytoma, IDH-mutant (9400/3)</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>02</td>
            <td class='code-desc'>Diffuse astrocytoma, IDH-wildtype (9400/3)</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>03</td>
            <td class='code-desc'>Anaplastic astrocytoma, IDH-mutant (9401/3)</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>04</td>
            <td class='code-desc'>Anaplastic astrocytoma, IDH-wildtype (9401/3)</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>05</td>
            <td class='code-desc'>Glioblastoma, IDH-wildtype (9440/3)</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>06</td>
            <td class='code-desc'>Oligodendroglioma, IDH-mutant and 1 p/19q co-deleted (9450/3)</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>07</td>
            <td class='code-desc'>Anaplastic oligodendroglioma, IDH-mutant and 1 p/19q co-deleted (9451/3)</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>08</td>
            <td class='code-desc'>Medulloblastoma, SHH-activated and TP53-wildtype (9471/3)</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>09</td>
            <td class='code-desc'>Embryonal tumor with multilayered rosettes, C19MC-altered (9478/3)</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>85</td>
            <td class='code-desc'>Not applicable: Histology not 9400/3, 9401/3, 9440/3, 9450/3, 9451/3, 9471/3, 9478/3</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>86</td>
            <td class='code-desc'>Benign or borderline tumor</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>87</td>
            <td class='code-desc'>Test ordered, results not in chart</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>88</td>
            <td class='code-desc'>Not applicable: Information not collected for this case<br/>
                (If this item is required by your standard setter, use of code 88 will result in an edit error.)

            </td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>99</td>
            <td class='code-desc'>Not documented in patient record<br/>
                No microscopic confirmation<br/>
                Brain molecular markers not assessed or unknown if assessed

            </td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'></td>
            <td class='code-desc'></td>
        </tr>
    </table>
</div>
<div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div>